Doctors, Payors, Lab Directors, Patients Have Distinct Views on What’s Holding Up Precision Oncology
Although few would argue there are challenges to equitably implementing precision cancer care, the barriers flagged by a doctor trying to deliver biomarker-informed treatments are quite different from those experienced by a patient trying to access genomic profiling and targeted therapies, and still different from the views of an insurance company executive tasked with [...]